These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19881231)

  • 1. Japan aims toward appropriate concomitant use of antiplatelets and antisecretory agents?
    Fujishiro M
    Intern Med; 2009; 48(21):1845-6. PubMed ID: 19881231
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.
    Furuta T
    Intern Med; 2009; 48(21):1847-8. PubMed ID: 19881232
    [No Abstract]   [Full Text] [Related]  

  • 3. H2 Receptor Antagonists versus Proton Pump Inhibitors in Patients on Dual Antiplatelet Therapy for Coronary Artery Disease: A Systematic Review.
    Almufleh A; Ramirez FD; So D; Le May M; Chong AY; Torabi N; Hibbert B
    Cardiology; 2018; 140(2):115-123. PubMed ID: 29966126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial update II: TRITON-TIMI 38 provides reassurance on concomitant use of proton pump inhibitors and thienopyridines.
    Eur Heart J; 2009 Dec; 30(23):2820. PubMed ID: 19972642
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
    Hokimoto S; Matsui K; Oshima S; Noda K; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    J Cardiol; 2009 Aug; 54(1):71-5. PubMed ID: 19632523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.
    Bhala N; Taggar JS; Rajasekhar P; Banerjee A
    BMJ; 2011 Jul; 343():d4264. PubMed ID: 21778196
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute upper gastrointestinal bleeding after coronary intervention in acute myocardial infarction].
    Strobl S; Zuber-Jerger I
    Med Klin (Munich); 2010 Apr; 105(4):296-9. PubMed ID: 20455053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
    Cook D; Guyatt G
    N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
    [No Abstract]   [Full Text] [Related]  

  • 9. How to complete gastroduodenal protection in patients with bleeding risk?
    Durazzo M; Fagoonee S
    Minerva Endocrinol; 2018 Jun; 43(2):221. PubMed ID: 28895681
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis.
    Khan MY; Siddiqui WJ; Alvarez C; Aggarwal S; Hasni SF; Ahmad A; Eisen H
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):847-853. PubMed ID: 29596078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention.
    Hiew C; Duggan A; de Malmanche T; Hatton R; Baker F; Attia J; Collins N
    Intern Med J; 2012 Mar; 42(3):289-93. PubMed ID: 20492005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
    Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
    Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
    Juwana YB; Rasoul S; Ottervanger JP; Suryapranata H
    J Invasive Cardiol; 2010 Jul; 22(7):312-6. PubMed ID: 20603502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
    Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
    Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
    [No Abstract]   [Full Text] [Related]  

  • 16. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.
    Wu CY; Chan FK; Wu MS; Kuo KN; Wang CB; Tsao CR; Lin JT
    Gastroenterology; 2010 Oct; 139(4):1165-71. PubMed ID: 20600012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common drugs can harm elderly patients.
    Voelker R
    JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy: problems with listing patients receiving clopidogrel for re-transplantation.
    Movahed MR
    JACC Cardiovasc Interv; 2009 May; 2(5):474; author reply 474-5. PubMed ID: 19463475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.